Home › BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research
 

Keywords :   


BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research

2014-04-30 07:01:39| drugdiscoveryonline News Articles

BPS Bioscience, Inc. (BPS) is excited to announce a unique portfolio of 13 different mutant EZH2 complexes, including several markers for Weaver Syndrome

Tags: research cancer proteins syndrome

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.114 SnowMan
13.11hololive EXPO 2024 stage1
13.11ACROSPEED v-01
13.11 1-26
13.11SEVENTEEN ver.NET
13.11RISE OF THE FLOODBORN BOX
13.11
13.11Switch Lite &
More »